NATCO Pharma (NSE:NATCOPHARM, BOM:524816) has completed the acquisition of an additional 13.25% stake in South Africa's Adcock Ingram Holdings for about 1.81 billion South African rand.
The acquisition, completed through NATCO Pharma South Africa, increases NATCO's holding in Adcock Ingram to 49% from 35.75%, according to a Tuesday Indian bourse filing.
Shares of the pharma company fell nearly 1% in recent trade.